Search

Author/Creator Kadel, Edward E

1. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Issue 10064 (7th January 2017)

Authors:
Balar, Arjun V; Galsky, Matthew D; Rosenberg, Jonathan E; Powles, Thomas; Petrylak, Daniel P; Bellmunt, Joaquim; Loriot, Yohann; Necchi, Andrea; Hoffman-Censits, Jean; Perez-Gracia, Jose Luis; Dawson, Nancy A; van der Heijden, Michiel S; Dreicer, Robert; Srinivas, Sandy; Retz, Margitta M; Joseph,...
Journal:
Lancet
Issue:
Volume 389:Issue 10064(2017)
Page Start:
67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial. Issue 10122 (24th February 2018)

Authors:
Powles, Thomas; Durán, Ignacio; van der Heijden, Michiel S; Loriot, Yohann; Vogelzang, Nicholas J; De Giorgi, Ugo; Oudard, Stéphane; Retz, Margitta M; Castellano, Daniel; Bamias, Aristotelis; Fléchon, Aude; Gravis, Gwenaëlle; Hussain, Syed; Takano, Toshimi; Leng, Ning; Kadel, Edward E; Banchereau...
Journal:
Lancet
Issue:
Volume 391:Issue 10122(2018)
Page Start:
748
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. In silico tools for accurate HLA and KIR inference from clinical sequencing data empower immunogenetics on individual-patient and population scales. Issue 3 (17th September 2020)

Authors:
Chen, Jieming; Madireddi, Shravan; Nagarkar, Deepti; Migdal, Maciej; Vander Heiden, Jason; Chang, Diana; Mukhyala, Kiran; Selvaraj, Suresh; Kadel, Edward E; Brauer, Matthew J; Mariathasan, Sanjeev; Hunkapiller, Julie; Jhunjhunwala, Suchit; Albert, Matthew L; Hammer, Christian
Journal:
Briefings in bioinformatics
Issue:
Volume 22:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗